Misconceptions and Facts About Beta-Blockers

The American Journal of Medicine
Edgar ArgulianFranz H Messerli

Abstract

Beta-blockers are commonly used medications, and they have been traditionally considered "cardioprotective." Their clinical use appears to be more widespread than the available evidence base supporting their role in cardioprotection. Beta-blockers counteract neurohumoral activation in heart failure with reduced ejection fraction and offer both symptomatic improvement and reduction in adverse events. On the other hand, the use of beta-blockers in uncomplicated hypertension results in suboptimal outcomes compared to the established first-line antihypertensive agents. Providers at all levels should be familiar with common misconceptions regarding beta-blocker use in routine clinical practice.

Citations

May 30, 2020·Pharmaceuticals·Rita PeixotoMiguel Oliveira
May 10, 2020·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Goran KoracevicZaklina Ristic
Oct 1, 2019·Obstetrics and Gynecology·Franz H MesserliEmrush Rexhaj
Jul 31, 2021·American Journal of Preventive Cardiology·Harold E BaysPeter P Toth
May 1, 2020·American Journal of Preventive Cardiology·Harold Edward Bays

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Current Cardiology Reports
Sripal BangaloreFranz H Messerli
Journal of Clinical Pharmacy and Therapeutics
S L NuttallM J Kendall
JAMA : the Journal of the American Medical Association
M J Kendall, J D Cohen
© 2022 Meta ULC. All rights reserved